BCG Moreau Vaccine Safety Profile and NK Cells—Double Protection Against Disseminated BCG Infection in Retrospective Study of BCG Vaccination in 52 Polish Children with Severe Combined Immunodeficiency

OBJECTIVES: The aim of the study was to estimate the rate of adverse reactions to live BCG Moreau vaccine, manufactured by Biomed in Poland, in severe combined immunodeficiency (SCID) patients. MATERIAL: The profiles of 52 SCID patients vaccinated at birth with BCG, hospitalized in Children’s Memori...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:J Clin Immunol
Autores principales: Bernatowska, Ewa, Skomska-Pawliszak, Małgorzta, Wolska-Kuśnierz, Beata, Pac, Małgorzata, Heropolitanska-Pliszka, Edyta, Pietrucha, Barbara, Bernat-Sitarz, Katarzyna, Dąbrowska-Leonik, Nel, Bohynikova, Nadia, Piątosa, Barbara, Lutyńska, Anna, Augustynowicz, Ewa, Augustynowicz-Kopeć, Ewa, Korzeniewska-Koseła, Maria, Krasińska, Maria, Krzysztopa-Grzybowska, Katarzyna, Wieteska-Klimczak, Anna, Książyk, Janusz, Jackowska, Teresa, van den Burg, Mirjam, van Dongen, Jacques J. M., Casanova, Jean-Laurent, Picard, Capucine, Mikołuć, Bożena
Formato: Artigo
Lenguaje:Inglês
Publicado: Springer US 2019
Materias:
Original Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7082382/
https://ncbi.nlm.nih.gov/pubmed/31749033
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10875-019-00709-1
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares